Gene · 10987
Papers2,142
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,142
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RETRACTED: Circ_0084653 promotes the tumor progression and immune escape in triple-negative breast cancer via the deubiquitination of MYC and upregulation of SOX5. | Int J Biol Macromol | 2024 | 39278446 | PubTator, text mining | PubMed |
| GOLM1 dictates acquired Lenvatinib resistance by a GOLM1-CSN5 positive feedback loop upon EGFR signaling activation in hepatocellular carcinoma. | Oncogene | 2024 | 39251847 | PubTator, text mining | PubMed |
| Distal convoluted tubule-specific disruption of the COP9 signalosome but not its regulatory target cullin 3 causes tubular injury. | Am J Physiol Renal Physiol | 2024 | 39205661 | PubTator, text mining | PubMed |
| In the twilight zone of protein sequence homology: do protein language models learn protein structure? | Bioinform Adv | 2024 | 39183802 | PubTator, text mining | PubMed |
| Altered assembly paths mitigate interference among paralogous complexes. | Nat Commun | 2024 | 39169013 | PubTator, text mining | PubMed |
| STAMBPL1, transcriptionally regulated by SREBP1, promotes malignant behaviors of hepatocellular carcinoma cells via Wnt/β-catenin signaling pathway. | Mol Carcinog | 2024 | 39150093 | PubTator, text mining | PubMed |
| Discovering New Metallo-Deubiquitinase CSN5 Inhibitors by a Non-Catalytic Activity Assay Platform. | J Med Chem | 2024 | 39129245 | PubTator, text mining | PubMed |
| Deciphering COPS5 influence on immune infiltration and prognosis in head and neck squamous cell carcinoma. | Heliyon | 2024 | 39040236 | PubTator, text mining | PubMed |
| Integrative analysis of cancer multimodality data identifying COPS5 as a novel biomarker of diffuse large B-cell lymphoma. | Front Genet | 2024 | 38974382 | PubTator, text mining | PubMed |
| Mechanism for the initiation of spliceosome disassembly. | Nature | 2024 | 38925148 | PubTator, text mining | PubMed |
| The COP9 signalosome stabilized MALT1 promotes Non-Small Cell Lung Cancer progression through activation of NF-κB pathway. | Cell Biol Toxicol | 2024 | 38864940 | PubTator, text mining | PubMed |
| Deubiquitinase PSMD14 promotes tumorigenicity of glioblastoma by deubiquitinating and stabilizing β-catenin. | Biofactors | 2024 | 38696072 | PubTator, text mining | PubMed |
| MEN1 deficiency stabilizes PD-L1 and promotes tumor immune evasion of lung cancer. | Cancer Sci | 2024 | 38685894 | PubTator, text mining | PubMed |
| Oxidative Stress-Mediated RUNX3 Mislocalization Occurs Via Jun Activation Domain-Binding Protein 1 and Histone Modification. | Appl Biochem Biotechnol | 2024 | 38683453 | PubTator, text mining | PubMed |
| Global, site-resolved analysis of ubiquitylation occupancy and turnover rate reveals systems properties. | Cell | 2024 | 38626770 | PubTator, text mining | PubMed |
| COP9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma. | Aging (Albany NY) | 2024 | 38466642 | PubTator, text mining | PubMed |
| COP9 signalosome component CSN-5 stabilizes PUF proteins FBF-1 and FBF-2 in Caenorhabditis elegans germline stem and progenitor cells. | Genetics | 2024 | 38427913 | PubTator, text mining | PubMed |
| A novel CSN5/CRT O-GlcNAc/ER stress regulatory axis in platinum resistance of epithelial ovarian cancer. | Int J Biol Sci | 2024 | 38385070 | PubTator, text mining | PubMed |
| Experimental evidence for cancer resistance in a bat species. | Nat Commun | 2024 | 38360878 | PubTator, text mining | PubMed |
| Exploration of Diagnostic Deubiquitinating Enzymes in Endometriosis and Its Immune Infiltration. | Biochem Genet | 2024 | 38302849 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10987/papers?page=4